Stock GENZYME CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Genzyme Corporation

Equities

US3729171047

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Genzyme Corporation

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress
PU
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares
BU
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group
BU
GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program
BU
GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints
BU
GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year
BU
GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Chemical Co.
BU
GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
BU
GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter
BU
GENZYME CORP.GNL : Genzyme Statement on Discussions With Sanofi-Aventis
BU
GENZYME CORP.GNL : Genzyme Details Market Potential of Alemtuzumab for MS
BU
GENZYME CORP.GNL : Genzyme to Hold Investor Event on Alemtuzumab
BU
GENZYME CORP.GNL : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender Offer
BU
GENZYME CORP.GNL : Genzyme Completes Sale of Genetic Testing Business to LabCorp
BU
GENZYME CORP.GNL : Genzyme Successfully Meets First Milestones of FDA Consent Decree
BU
GENZYME CORP.GNL : Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.
BU
GENZYME CORP.GNL : Genzyme Responds to Sanofi-Aventis Letter
BU
GENZYME CORP.GNL : Genzyme Details Financial Recovery and Other Factors Driving Company's Value
BU
GENZYME CORP.GNL : Genzyme Announces Webcast of Analyst and Investor Event
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Genzyme Corporation